


Finkelstein Thompson LLP Announces Investigation of Cogent, Inc.
WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cogent Inc. (aCogenta or the aCompanya) (Nasdaq: COGT) concerning the proposed sale of the Company to 3M for approximately $10.50 per share.
The investigation is focused on the potential unfairness of the price to Cogenta™s shareholders and the process by which the Cogent Board of Directors shopped the Company and considered the transaction. In particular, according to Yahoo! Finance, at least one analyst has set a target price of $16.00 for Cogent stock, and the Companya™s shares traded as high as $11.29 as recently as January 21, 2010. The investigation is also focused on potential conflicts of interests on the part of Board members, particularly in light of the Companya™s announcement that Ming Hsieh, Cogenta™s CEO and Chairman of the Board, will aremain an integral parta of the new company if the deal is consummated.
If you are interested in discussing your rights as a Cogent shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.